PipelinePharma Logo

esketamine Nasal spray 28 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #21467

This global pharmaceutical company is dedicated to improving patients' lives through high-quality, differentiated products and services. They leverage a collaborative network to achieve success in key regions like the EU and North America. Their focus areas include women's health, infectious diseases, and potentially other therapeutic areas based on their recent approvals and launches. They produce prescription medications (including injectables) and tablets, demonstrating expertise in various dosage forms. The company holds GMP certifications and boasts successful product patents, solidifying its commitment to quality and innovation.

Manufacturer usually replies in 12 days

Esketamine MANUFACTURERS

Markets of interest
Esketamine is prescribed for treatment-resistant depression (Major Depressive Disorder in adults who have not responded adequately to at least two different antidepressants of adequate dose and duration to treat the current depressive episode). The medication is associated with AMPA receptor activation which increases signaling of neurotrophic factors supporting both rapid onset and long term antidepressant effects. The substance is available for sale in the form of ampoules (at concentration 25mg/ml-10ml )from manufacturers in various countries including Y. The drug is provided by a wide range of esketamine suppliers from various countries including the Y, Y, and Y. Mostly due to the availability of raw materials for the manufacturing process and low labor costs, the leading esketamine manufacturers and distributors are based in India and the USA.

Licensing and brand names

Under the trade name Spravato (by Janssen Pharmaceuticals), esketamine, on March 5, 2019 was approved by the FDA for treatment-resistant major depression. The medication is presently approved in many countries.
One of the more popular branded versions of esketamine is manufactured and supplied by the company a. Other manufacturing companies and distributors have also successfully adapted to the demands of the global marketplace and produce a variant of the drug with esketamine as an active ingredient.

Target supply price

The wholesale acquisition cost of medication in the U.S. is approximately 80 USD for the supply of tablets that contain up to of the substance each. The retail price in the EU of this drug depending on the number of tablets in the pack and substance’s concentration in one tablet ranges between EUR and EUR. The medication wholesale prices and commercial terms can vary depending on the supplier.

Information from manufacturers

We provide a detailed list of the esketamine manufacturers and suppliers that you are looking for. You can also find the dossier status of esketamine and the GMP approvals of the different variants of the medication. The product description of all esketamine suppliers contain essential information about the medication you order including clinical data, stability zones, and a list of countries where esketamine is already registered in. Manufacturers also specify the commercial terms of their offers, such as the market for which the offer is intended, deal type, dossier licensing fee, supply price, payment terms as well as delivery terms.Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified esketamine suppliers and distributors enter our online marketplace, offering you a risk-free global B2B pharmaceutical sales platform.